Author:
Oshansky Christine M.,Zhou James,Gao Yonghong,Schweinle Jo Ellen,Biscardi Karen,DeBeauchamp Jennifer,Pavetto Corrina,Wollish Amy,Webby Richard J.,Cioce Vittoria,Donis Ruben O.,Bright Rick A.
Funder
Biomedical Advanced Research and Development AuthorityBiomedical Advanced Research and Development Authority (BARDA)
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference25 articles.
1. Centers for Disease Control and Prevention. Influenza Risk Assessment Tool (IRAT). Internet.
2. U.S. department of health and human services pandemic influenza plan 2017 Update. In: Services HaH, editor. Centers for Disease Control and Prevention; 2017.
3. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine;Treanor;New England J Med,2006
4. Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults;Bernstein;J Infect Dis,2008
5. Effect of varying doses of a monovalent H7N9 influenza vaccine with and without AS03 and MF59 adjuvants on immune response: a randomized clinical trial;Jackson;JAMA,2015
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献